Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001493152-26-005226
Filing Date
2026-02-05
Accepted
2026-02-05 11:33:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B form8a-12b.htm 8-A12B 54085
  Complete submission text file 0001493152-26-005226.txt   55430
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-11460 | Film No.: 26601313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)